AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
Bajaj Healthcare Board Approves Q3 FY26 Results, Reappoints Key Directors
Bajaj Healthcare Limited
January 19, 2026, 11:23 AM
Bajaj Healthcare's Board approved Q3 FY26 un-audited results. Key directors, including Chairman & MD Mr. Sajankumar Rameshwarlal Bajaj, were re-appointed for three-year terms starting April 1, 2026. The re-appointments are subject to shareholder approval.
Top Queries to Ask About Bajaj Healthcare Limited
InstantThinking to buy or sell Bajaj Healthcare Limited? Ask AI before you act.
Trusted by 5,000+ users
More Details on This News
Bajaj Healthcare Limited announced the outcome of its Board Meeting held on January 16, 2026. The Board approved the un-audited financial results for the quarter and nine months ended December 31, 2025, along with the Limited Review Report from statutory auditors Walker Chandiok & Co. LLP.
Furthermore, the Board approved the re-appointment of key managerial personnel. Mr. Sajankumar Rameshwarlal Bajaj was re-appointed as Chairman & Managing Director for a three-year term from April 1, 2026, to March 31, 2029. Similarly, Mr. Anil Champalal Jain was re-appointed as Managing Director, and Ms. Namrata Sajankumar Bajaj and Mr. Pakshal Anil Jain were re-appointed as Whole-Time Directors for similar terms, all subject to shareholder approval.
The Board Meeting commenced at 4:15 p.m. and concluded at 5:00 p.m. The company also informed about the notice of Postal Ballot pursuant to the Companies Act, 2013.
More News on Bajaj Healthcare Limited
Analyze Bajaj Healthcare Limited